CAREDX, INC. Finance Lease, Right-of-Use Asset, Amortization
CAREDX, INC. (CDNA) reported Finance Lease, Right-of-Use Asset, Amortization of $1.37 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-07-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2021-07-29
- CAREDX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $689.00K, a 6.99% increase year-over-year.
- CAREDX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $677.00K, a 10.62% increase year-over-year.
- CAREDX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-12-31 was $642.00K, a 30.49% increase year-over-year.
- CAREDX, INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-09-30 was $640.00K, a 31.03% decline year-over-year.
- CAREDX, INC. finance lease, right-of-use asset, amortization for fiscal 2020 was $2.54M, a 56.57% increase from fiscal 2019.
- CAREDX, INC. finance lease, right-of-use asset, amortization for fiscal 2019 was $1.62M.
- CAREDX, INC. finance lease, right-of-use asset, amortization for fiscal 2018 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2021-06-30 | $689.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.37M 10-Q · filed 2021-07-29 | $2.01M derived: sum of 3 quarters · filed 2021-07-29 | $2.65M derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | $677.00K 10-Q · filed 2021-05-05 | $1.32M derived: sum of 2 quarters · filed 2021-05-05 | $1.96M derived: sum of 3 quarters · filed 2021-05-05 | $2.60M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.28M derived: sum of 2 quarters · filed 2021-02-24 | $1.93M derived: sum of 3 quarters · filed 2021-07-29 | $2.54M 10-K · filed 2021-02-24 |
| 2020-09-30 | $640.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.28M derived: sum of 2 quarters · filed 2021-07-29 | $1.90M 10-Q · filed 2020-10-29 | $2.39M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-06-30 | $644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.26M 10-Q · filed 2021-07-29 | $1.75M derived: sum of 3 quarters · filed 2021-07-29 | $2.68M derived: sum of 4 quarters · filed 2021-07-29 |
| 2020-03-31 | $612.00K 10-Q · filed 2021-05-05 | $1.10M derived: sum of 2 quarters · filed 2021-05-05 | $2.03M derived: sum of 3 quarters · filed 2021-05-05 | $1.86M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $492.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.42M derived: sum of 2 quarters · filed 2021-02-24 | $1.25M derived: sum of 3 quarters · filed 2021-02-24 | $1.62M 10-K · filed 2021-02-24 |
| 2019-09-30 | $928.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $757.00K derived: sum of 2 quarters · filed 2020-10-29 | $1.13M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $201.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $372.00K 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |